CXCL8 and gastric cancer: In fact, CXCL-8 levels positively correlate to poor clinical outcomes for patients who have gastric cancer, decreasing CD8+ T cell infiltration and increasing immunosuppressor programmed death ligand 1 (PD-L1) expression on macrophages (Lin et al., 2019).